Daniela Knafelz

Dr. Daniela Knafelz


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Inflammatory Bowel Diseases
Verified
Journal Article
Closed access
PDF file
MCM. Castro
M. Castro
BPB. Papadatou
B. Papadatou
Maria Elisabetta BaldassarreMaria Elisabetta Baldassarre
Maria Elisabetta Baldassarre
FBF. Balli
F. Balli
ABA. Barabino
A. Barabino
MZM. G. Zaniboni
M. G. Zaniboni

1 September 2008 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
ADAntonella Diamanti
Antonella Diamanti
FCF. Colistro
F. Colistro
MBM. S. Basso
M. S. Basso
BPB. Papadatou
B. Papadatou
PFP. Francalanci
P. Francalanci
MCM. Castro
M. Castro
Background. Inflammatory bowel diseases (IBD) are characterized by periods of remission with recurrent episodes of symptom exacerbation because of acute intesti

1 October 2008 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
MSMichela G Schäppi
Michela G Schäppi
OBOsvaldo Borrelli
Osvaldo Borrelli
DKDaniela Knafelz
Daniela Knafelz
SWSue Williams
Sue Williams
VSVirpi V Smith
Virpi V Smith
KLKeith J Lindley
Keith J Lindley

1 April 2007 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
MCM Castro
M Castro
LRL Rossi
L Rossi
BPB Papadatou
B Papadatou
FBF Bracci
F Bracci
DKDaniela Knafelz
Daniela Knafelz
Mauro MagnaniMauro Magnani
Mauro Magnani

1 January 2019 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
LRLissy de Ridder
Lissy de Ridder
AAAmit Assa
Amit Assa
JBJiri Bronsky
Jiri Bronsky
CRClaudio Romano
Claudio Romano
RRRichard K. Russell
Richard K. Russell
PEPaediatric IBD Porto group of ESPGHAN
Paediatric IBD Porto group of ESPGHAN

1 November 2010 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
ADAntonella Diamanti
Antonella Diamanti
FPF. Panetta
F. Panetta
MBM. S. Basso
M. S. Basso
AFA. Forgione
A. Forgione
FCF. Colistro
F. Colistro
MCM. Castro
M. Castro
Background. Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support i